NCT00041613View on ClinicalTrials.gov

Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate

PHASE3UnknownINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Carcinoma, Squamous Cell
Interventions
GENETIC

INGN 201

Trial Locations (5)

21204

RECRUITING

Cancer Center of GBMC, Baltimore

29209

RECRUITING

WJB Dorn VA Medical Center, Columbia

40202

RECRUITING

Norton Healthcare Pavilion, Louisville

75201

RECRUITING

Mary Crowley Medical Research Center, Dallas

80045

RECRUITING

Unversity of Colorado Cancer Center, Aurora

Sponsors
All Listed Sponsors
lead

Introgen Therapeutics

INDUSTRY